These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11832714)

  • 1. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
    Miyake H; Hara I; Kamidono S; Eto H
    J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Competitive Reverse Transcription-Polymerase Chain Reaction Analysis of Specific CD44 Variant RNA for Detecting Upper Urinary Tract Transitional-Cell Carcinoma.
    Miyake H; Hara I; Arakawa S; Kamidono S
    Mol Urol; 1999; 3(4):365-370. PubMed ID: 10851297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia.
    Woodman AC; Goodison S; Drake M; Noble J; Tarin D
    Clin Cancer Res; 2000 Jun; 6(6):2381-92. PubMed ID: 10873090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8-10/CD44v10 competitive RT-PCR.
    Miyake H; Okamoto I; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S; Saya H
    Int J Cancer; 1998 Dec; 79(6):560-4. PubMed ID: 9842962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of CD44 variant isoform in urine samples of urothelial cancer patient].
    Hara I; Miyake H; Gohji K; Arakawa S; Kamidono S
    Hinyokika Kiyo; 1999 Aug; 45(8):589-92. PubMed ID: 10500968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.
    Masuda M; Takano Y; Iki M; Makiyama K; Noguchi S; Hosaka M
    J Urol; 1999 Mar; 161(3):805-8; discussion 808-9. PubMed ID: 10022688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes.
    Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
    Am J Pathol; 1998 May; 152(5):1157-60. PubMed ID: 9588883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.
    Durkan GC; Nutt JE; Marsh C; Rajjayabun PH; Robinson MC; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2003 Jul; 9(7):2576-82. PubMed ID: 12855633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome.
    Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Garraway I; Wong SG; Belldegrun AS; Pantuck AJ
    J Urol; 2010 Jun; 183(6):2403-8. PubMed ID: 20403620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of aneusomy of chromosomes in exfoliated urothelial cells to predict the recurrence of superficial bladder cancer after complete transurethral resection].
    Bao QB; Liu J; Sun HB; Su JH; Zhu JG; Lin JZ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):548-51. PubMed ID: 19567078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with hyaluronic acid and potentiates their malignant progression.
    Muramaki M; Miyake H; Kamidono S; Hara I
    J Urol; 2004 Jan; 171(1):426-30. PubMed ID: 14665947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive loss of CD44 gene expression in invasive bladder cancer.
    Sugino T; Gorham H; Yoshida K; Bolodeoku J; Nargund V; Cranston D; Goodison S; Tarin D
    Am J Pathol; 1996 Sep; 149(3):873-82. PubMed ID: 8780391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.